Technology gives labs a hand with utilization management September 16, 2019 -- Lab testing is notoriously prone to errors of overuse and underuse, with serious financial and clinical consequences. When word of mouth isn't enough to change course, machine-learning models and computerized systems for monitoring the use of tests can step in with objective support, new studies show. Discuss
Roche's cobas pro clears FDA September 16, 2019 -- Roche Diagnostics said the U.S. Food and Drug Administration (FDA) has cleared its cobas pro integrated solutions for high-volume clinical chemistry and immunochemistry testing in labs.
Sysmex drives Clinical Lab 2.0 anemia project September 16, 2019 -- Sysmex America is providing a grant to the Clinical Lab 2.0 value-based laboratory initiative to support a multi-institutional demonstration project related to the early detection, intervention, and prevention of anemia.
Point-of-care testing tackles diabetes risk in Texas September 12, 2019 -- One of the key advantages of point-of-care (POC) testing is the ability to offer test results within a matter of minutes, instead of several hours or a few days with central lab testing. Health officials in Texas were able to leverage POC technology to boost participation in a program designed to tackle one county's growing diabetes epidemic. Discuss
Quest, Hc1 debut lab test utilization service September 12, 2019 -- Quest Diagnostics and bioinformatics company Hc1 have announced the debut of Quest Lab Stewardship, a machine learning-powered program for tracking and monitoring the appropriateness of lab testing across health systems.
CAP offers guideline on molecular testing in brain cancer September 9, 2019 -- The College of American Pathologists (CAP) on September 9 released new draft recommendations on biomarkers for diffuse gliomas, the most common group of primary brain tumors. The move recognizes the growing importance of molecular testing in tumor classification. Discuss
AMP spells out how labs should report genetic test results September 4, 2019 -- The Association for Molecular Pathology (AMP) has provided guidance on best practices for pharmacogenomic tests, including quality, compliance with CLIA, and reporting of results to health providers, in a position statement released on September 4. Discuss
USPSTF proposes big expansion of hepatitis C screening August 28, 2019 -- The U.S. Preventive Services Task Force (USPSTF) has vastly expanded its stance on screening for hepatitis C to include all adults -- not just baby boomers and those at high risk -- in a draft recommendation statement published on August 27. Discuss
Urine tests at root of antibiotic misuse in Blue Cross study August 28, 2019 -- Urine testing is resulting in the inappropriate treatment of asymptomatic bacteriuria with antibiotics and longer hospital stays, according to a study funded by Blue Cross Blue Shield of Michigan and published online August 26 in JAMA Internal Medicine. Discuss